Cancer cells turn to cannibalism to survive chemotherapy, study suggests

Cancer cells turn to cannibalism to survive chemotherapy, study suggests
This image of a breast tumor formed in mice and treated with the chemotherapy drug doxorubicin shows that some cancer cells (red nuclei) have been engulfed by other cancer cells (green cell membrane). Credit: Tonnessen-Murray et al., 2019

Researchers from the Tulane University School of Medicine have discovered that some cancer cells survive chemotherapy by eating their neighboring tumor cells. The study, which will be published September 17 in the Journal of Cell Biology, suggests that this act of cannibalism provides these cancer cells with the energy they need to stay alive and initiate tumor relapse after the course of treatment is completed.

Chemotherapy drugs such as doxorubicin kill cancer cells by damaging their DNA, but cells that survive initial treatment can soon give rise to relapsed tumors. This is a particular problem in breast cancers that retain a normal copy of a gene called TP53. Instead of dying in response to -induced DNA damage, these cancer cells generally just stop proliferating and enter a dormant but metabolically active state known as senescence. In addition to surviving chemotherapy, these senescent cancer cells produce large amounts of inflammatory molecules and other factors that can promote the tumor's regrowth. Chemotherapy-treated with normal TP53 genes are therefore prone to relapse and have poor survival rates.

"Understanding the properties of these senescent cancer cells that allow their survival after chemotherapy treatment is extremely important," says Crystal A. Tonnessen-Murray, a postdoctoral research fellow in James G. Jackson's laboratory at the Tulane University School of Medicine.

A doxorubicin-treated senescent breast cancer cell (green) engulfing a neighboring cancer cell (red). Credit: Tonnessen-Murray et al., 2019

In the new study, Tonnessen-Murray and colleagues discovered that, after exposure to doxorubicin or other , breast cancer cells that become senescent frequently engulf neighboring cancer cells. The researchers observed this surprising behavior not only in cancer cells grown in the lab, but also in tumors growing in mice. Lung and bone cancer cells are also capable of engulfing their neighbors after becoming senescent, the researchers discovered.

Tonnessen-Murray and colleagues found that senescent cancer cells activate a group of genes that are normally active in that engulf invading microbes or cellular debris. After "eating" their neighbors, senescent cancer cells digested them by delivering them to lysosomes, acidic cellular structures that are also highly active in senescent cells.

Breast cancer cells (red) being engulfed and delivered to the lysosomes (green) of a doxorubicin-treated senescent breast cancer cell. Credit: Tonnessen-Murray et al., 2019

Importantly, the researchers determined that this process helps senescent cancer cells stay alive. Senescent cancer cells that engulfed a neighboring cell survived in culture for longer than senescent cancer that didn't. The researchers suspect that consuming their neighbors may provide senescent with the energy and materials they need to survive and produce the factors that drive tumor relapse.

"Inhibiting this process may provide new therapeutic opportunities, because we know that it is the patients with tumors that undergo TP53-mediated senescence in response to chemotherapy that have  poor response and poor survival rates," Jackson says.

More information: Tonnessen-Murray et al., 2019. J. Cell Biol.

Journal information: Journal of Cell Biology
Citation: Cancer cells turn to cannibalism to survive chemotherapy, study suggests (2019, September 17) retrieved 16 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Researchers design a nano-carrier to release drugs into damaged cells


Feedback to editors